Heterocyclic inhibitors of ATR kinase
The present invention relates to heterocyclic compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.
Board of Regents, The University of Texas System ChemPartner Corporation
C C A
C07D C07D A61P
inventional inventional inventional
Michael Garrett Sarah Christopher Lawrence Zhijun Jason Bryant Philip Maria Emilia
Johnson Lively Carroll Kang Cross Jones Di Francesco